68Ga‐labeled prostate‐specific membrane antigen ligand using positron emission computed tomography (Ga68 PSMA‐PET/CT) is also used in the evaluation of the patients with PCa in terms of location of the cancer in the prostate, lymph node (LN) involvement and systemic metastasis. The gene discussed is FOLH1; the disease is posterior cortical atrophy.